Table 2.
Chronic CAP exposure impacts lipid metabolism.
| Lipid | Metabolites | CAP/FA ratio | p value |
|---|---|---|---|
| Sphingolipid | SM(d16:1/18:1) | 1.39 | 0.0059 |
| GlcCer(d18:1/14:0) | 3.79 | 0.0111 | |
| Psychosine sulfate | 31.39 | 0.0274 | |
| Sterol lipid | 1alpha-hydroxy-23-[3-(1-hydroxy-1-methylethyl) phenyl]-22,22,23,23-tetradehydro-24,25,26,27-tetranorvitamin D3 /1alpha-hydroxy-23-[3-(1-hydroxy-1-methylethyl) phenyl]-22,22,23,23-tetradehydro-24,25,26,27-tetranorcholecalciferol | 1.58 | 0.0052 |
| Taurochenodeoxycholic acid 7-sulfate | 0.72 | 0.0226 | |
| Prenol lipid | D-Limonene | 4.92 | 0.0069 |
| Coenzymes QH2 | 3.04 | 0.0214 | |
| (−)-Fusicoplagin A | 0.66 | 0.0314 | |
| Plastoquinol-1 | 5.66 | 0.0458 | |
| Glycerolipid | TG(14:1(9Z)/18:1(11Z)/14:1(9Z)) | 1.29 | 0.0249 |
| MG(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) | 2.35 | 0.0342 | |
| Lysophospholipid | LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)) | 0.66 | 0.0048 |
| LysoPC(18:0) | 0.48 | 0.0190 | |
| LysoPC( 18:3(6Z,9Z, 12Z)) | 1.35 | 0.0112 | |
| LysoPE(18:0/0:0) | 1.12 | 0.0123 | |
| Glycerophospholipid | PA(P-16:0/15:1(9Z)) | 12.59 | 0.0025 |
| PA(P-16:0/20:5(5Z,8Z,11Z,14Z,17Z)) | 0.53 | 0.0312 | |
| PA(18:1(9Z)/22:2(13Z,16Z)) | 1.1 | 0.0337 | |
| PC(13:0/0:0) | 1.2 | 0.0031 | |
| PC(10:0/4:0) | 0.69 | 0.0032 | |
| PC(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) | 0.81 | 0.0113 | |
| PC(15:0/18:1(11Z)) | 1.67 | 0.0140 | |
| PC(16:0/P-18:0) | 2.17 | 0.0159 | |
| PC(14:0/20:1(11Z)) | 1.13 | 0.0192 | |
| PC(P-17:0/0:0) | 1.43 | 0.0350 | |
| PC(18:2(9Z,12Z)/P-18:1(11Z)) | 2.43 | 0.0403 | |
| PC(15:0/22:4(7Z,10Z,13Z,16Z)) | 1.6 | 0.0414 | |
| PC(22:5(7Z,10Z,13Z,16Z,19Z)/16:0) | 0.81 | 0.0445 | |
| PC(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 0.79 | 0.0479 | |
| PC(20:3(5Z,8Z,11Z)/P-18:1(11Z)) | 3.07 | 0.0499 | |
| PE(P-16:0/0:0) | 1.53 | 0.0025 | |
| PE(22:4(7Z,10Z,13Z,16Z)/P-18:1(11Z)) | 0.45 | 0.0026 | |
| PE(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 3.74 | 0.0060 | |
| PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) | 1.27 | 0.0075 | |
| PE(18:3(6Z,9Z,12Z)/P-18:1(11Z)) | 3.24 | 0.0112 | |
| PE(O-18:1(1Z)/20:4(5Z,8Z,11Z,14Z)) | 2.11 | 0.0138 | |
| PE(18:0/20:4(5Z,8Z,10E,14Z)(12OH[S])) | 0.71 | 0.0149 | |
| PE(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) | 6.91 | 0.0308 | |
| PE(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 4.02 | 0.0325 | |
| PI(P-16:0/12:0) | 1.75 | 0.0016 | |
| PI (O-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 2.58 | 0.0415 | |
| PS(19:1(9Z)/22:4(7Z,10Z,13Z,16Z)) | 0.78 | 0.0037 | |
| PS(16:0/22:2(13Z,16Z)) | ∞* | 0.0056 | |
| PS(17:1(9Z)/0:0) | 2.27 | 0.0101 | |
| PS(19:0/0:0) | 10.89 | 0.0126 | |
| PS(O-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 0.1 | 0.0390 | |
| PS(17:1(9Z)/22:2(13Z,16Z)) | 0.48 | 0.0398 | |
| CPA(18:0) | 2.27 | 0.0203 |
*:
PS(16:0/22:2(13Z,16Z)) was not detected in FA exposed samples.